4-1BB
AEG-1
AFP
AFP serum level
AKT
APC
APCs
ARG1
Adaptive resistance
Adenosine
Adoptive cell transfer
Alpha-fetoprotein
Anergic T cells
Angiogenesis
Anti-CTLA-4 therapy
Anti-PD-1 therapy
Anti-PD-L1 therapy
Anti-angiogenic therapy
Antigen loss
Antigen presentation
Arginase
Arginase-1
Atezolizumab
B cell receptor
B cells
B-Raf proto-oncogene
B7
B7 homolog 1
B7-DC
B7-H3
B7-H4
B7–H1
BCG
BCR
BRAF mutation
BRM
BRM therapy
BTLA
BVD 523
Bacillus Calmette Guerin
Biological Response Modifier
Breast cancer
C-terminal subunit
CAFs
CANs
CAR
CAR T cells
CAR-T cell therapy
CCL2
CCL5
CCL5 receptor
CCR5
CD 273
CD11b
CD137
CD14
CD152
CD163
CD206
CD25
CD274
CD279
CD28
CD3
CD31
CD33
CD39
CD4
CD40
CD40L
CD4⁺ T cells
CD56
CD68
CD73
CD8
CD8 +
CD80
CD86
CD8⁺ T cells
COX-2
CTCs
CTLA-4
CTLA-4 inhibitors
CTLs
CTNNB1 mutation
Cancer stem cells
Cancer vaccines
Cancer-associated fibroblasts
Cancer-associated neutrophils
Caspase-3
Caspase-8
Central memory T cells
Chimeric antigen receptor
Chronic hepatitis
Chronic inflammation
Circulating tumor DNA
Circulating tumor cells
cluster of differentiation 279
cluster of differentiation 8 +
Collagen
Colorectal cancer
Combination immunotherapy
Conventional dendritic cells
Cytotoxic T lymphocyte-associated protein-4
Cytotoxic T lymphocytes
Cytotoxic T-lymphocyte -associated protein 4
Cytotoxic T-lymphocyte-associated protein 4
DCs
DNA methyltransferases
DNA vaccine
DNMTs
Dendritic cells
Dual checkpoint blockade
Durvalumab
E-cadherin
ECM
EGF
EGFR
EMA
EMT
ERK
ERK 42
ERK signalling
ERK1/2
EVs
Effector memory T cells
Endothelial cells
ErbB
Exhausted T cells
Exosomes
Extracellular matrix
Extracellular vesicles
FAK
FAP
FGF
FGFR
FOXP3
FZD
Fibronectin
Fibrosis
Freund’s adjuvants
G-38963
GATA3
GC33
GLUT1
GM-CSF
GP 96
GPC- 3
GPC3
GSK3β
Galectin-9
Gastric cancer
Glycoprotein 96
Glypican-3
HBV
HCC
HCC Hepatocellular carcinoma
HCV
HDACs
HER2
HGF
HIF
HIF-1α
HLA G
HLA-G
HN3
HS20
HSE
HSFs
HSP
HSP 70
HSP27
HSP40
HSP70
HSP90
HSPPC 96
HSPs
Heat shock protein
Heat shock protein-peptide complex 96
Heat shock proteins
Hepatic stellate cells
Hepatitis B virus
Hepatitis C virus
Human leukocyte antigen G
Human single domain antibodies
Hyaluronic acid
Hypoxia
ICAM-1
ICOS
IDO
IDO1
IFN
IFN-α
IFN-β
IFN-γ
IGFBP7
IHS
IL
IL-1
IL-10
IL-12
IL-17
IL-18
IL-2
IL-21
IL-22
IL-23
IL-27
IL-4
IL-6
IL-8
IQGAP1
ITSM
Immune checkpoint upregulation
Immune evasion
Immune infiltration score
Immunosuppression
Indoleamine 23-dioxygenase
Integrins
JAK-STAT
JAK/STAT pathway
JAK1
JAK2
JAK2/STAT3
JNK
JNK2
JNKs
KRAS mutation
Kupffer cells
LAG-3
LEF-1
LPS
LRR
LYRIC
Lactate
Laminin
Lenvatinib
Ligands
Lipopolysaccharide
Liver cirrhosis
Liver fibrosis
Lung cancer
MAP kinase
MAPK
MAPK pathway
MAPK pathways
MAPK signaling pathways
MAPK-pathways
MAPKs
MAPKs pathways
major histocompatibility complexes
major histocompatibility complex II
MDSCs
MEK
MEKK2
MHC
MHC 1
MHC 2
MHC I
MHC II
MHC class I
MHC class II
MHC-I
MHC-II
MHCs
MIC
MMP-2
MMP-9
MMPs
MSI
MTDH
MUC 1
MUC1
Mast cells
Matrix metalloproteinases
Melanoma
Memory T cells
Mesenchymal stem cells
Metadherin
Metastasis
Microsatellite instability
Microvesicles
Mitogen Activated Protein Kinase
Mitogen-activated protein kinase
Monocytes
Mucin 1
Mucins
MyD88
Myeloid-derived suppressor cells
N-cadherin
N-cadherin markers
N-glycan
N-terminal subunit
NAFLD
NASH
NF-κB
NF-κB pathway
NF-κβ
NFAT
NK cell
NK cell receptors
NK cells
NKG2D
NKp30
NKp46
NLR
NLRs
NO
NOD
NOD-like receptors
NOD1
NOD2
NY-ESO-1
Neoantigen vaccine
Neoantigens
Neutrophils
Nitric oxide
Nivolumab
Non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis
O-glycan
O-linked glycosylation
OX40
OX40L
Oncolytic virus therapy
P13K
P13Ks
PAMP
PAMPs
PD 1
PD L1
PD L2
PD-1
PD-L1
PD-L2
PD1
PDCD1
PDCD1LG2
PDGF
PDL1
PEM
PI3K
PI3K signaling
PI3K/AKT pathway
PI3K/EKT
PI3Ks
PI3Kδ inhibitors
PRRs
Pancreatic cancer
Pathogen associated molecular patterns
Pembrolizumab
Pericytes
Personalized immunotherapy
Phosphoinositide 3-kinases
Plasma cells
Plasmacytoid dendritic cells
Primary resistance
Programmed death ligand 1
Programmed death receptor-1
Prostaglandin E2
Prostate cancer
Pyk2
RANTES
RIG-I
RIG-I-like receptors
RLRs
RORγt
ROS
Raf
Ras
Reactive oxygen species
Regorafenib
Regulatory T cells
Renal cell carcinoma
SHP-1
SHP-2
SMAD
SMAD2
SMAD3
SMAD4
STAT1
STAT3
STAT5
Selectins
Selumetinib
Sorafenib
Src
Stromal compartment
T cell
T cell exhaustion
T cell immunotherapies
T cell receptor
T cell receptors
T cells
T lymphocyte
T-cell
T-cell engaging bispecific antibodies
T-cell receptor
T-cells
TA
TAA
TAAs
TAMs Tumor-associated macrophages
TCR
TCR-T therapy
TDO
TGF- beta
TGF-β
TGF-β signaling pathway
TGFβ
TIGIT
TIL therapy
TIM-3
TIR
TLR
TLR2
TLR3
TLR4
TLR7
TLR8
TLR9
TLRs
TMB
TME
TNF-α
TNFα
TP53 mutation
TSA
TSAs
Tenascin-C
Th1
Th1 cells
Th17 cells
Th2
Th2 cells
Tissue-resident memory T cells
Trametinib
Treg
Tregs
Tryptophan 23-dioxygenase
Tumor antigens
Tumor cells
Tumor heterogeneity
Tumor immune evasion
Tumor microenvironment
Tumor mutational burden
Tumor-associated antigens
Tumor-specific MHC-II
Tyrosine-Based Switch Motif
VEGF
VEGF signaling pathway
VEGF-A
VEGFR-2
VISTA
Viral hepatitis
WNT catenin
WNT catenin pathways
Wnt
Wnt/β-catenin pathway
YP7
activated cytotoxic T-cells
amino acids
anti-CTLA antibodies
antigen-MHC complex
antigen-presenting cells
antigens
apoptosis
arabinogalactomannan
astrocyte elevated gene-1 protein
bacillus Calmette-Guérin
biosynthesis
breast
c-Jun N-terminal kinases
c-Myc
cDC1
cDC2
cancer cell
cancer cell survival
cancer cells
cancer immunotherapy
cancer proliferation
cell differentiation
cell membrane
cell migration
cell motility
cell proliferation
cell survival
cervical cancer
checkpoint inhibitors
chemokine CCL5
chemotherapy
Chimeric Antigen Receptor T cells
chondrosarcoma cells
cluster of differentiation 274
cluster of differentiation 279
cluster of differentiation 8 +
colon
colon carcinoma
ctDNA
cytokines
cytotoxic T
cytotoxic T cell
cytotoxic T cells
cytotoxic T-cell signalling
dendritic cell-based vaccine
epithelial cells
epithelial membrane antigen
epithelial mesenchymal transition
extracellular signal-regulated kinase
eyes
Gene therapy
glioma
glycoprotein
glycosylphosphatidylinositol linkage
granulocyte–macrophage colony-stimulating factor
hYP7
heat shock
heat shock elements
heat shock transcription factors
heparan sulfate
heparan sulfate proteoglycan
heparan sulphate
hepatocellular carcinoma
hippo pathways
histocompatibility antigen class I G
immune cell
immune protein
immune regulation
immune system
immunotoxins
indoleamine 2,3-dioxygenase dioxygenase 1
interleukin
intestines
keyhole limpet hemocyanin
liver
lung
lung adenocarcinoma
lungs
lymphocyte
lymphocyte-associated protein 4
lymphocytic leukemia
lymphoid enhancer binding factor 1
mRNA
mTOR
macrophage
macrophages
major histocompatibility complex
major histocompatibility complex II
malignant cells
mannan
mature cytotoxic T-cells
metalloproteinases-3
metastatic
metastatic pathways
mice
mitogens
myeloid-derived suppressor cells
neoplastic cells
nod like receptor
nucleotide-binding oligomerization domain
oestrogen receptor
oligosaccharides
oncogenic pathways
osmotic stress
ovarian
ovarian carcinoma
p38
p53
paclitaxel
pancreatic cancers
pattern recognition receptors
PD-1 ligand 2
peptide/protein vaccines
peptidoglycan
polymorphic epithelial mucin
pro-B cells
programmed cell death
programmed cell death protein 1
programmed cell death protein ligand 1
programmed death ligand-1
proto-oncogenes
radiation
ragweed-TLR9
regulatory T cells
regulatory T-cells
retinoid acid-inducible gene I
sMIC
saponin
serine
serine kinase
snail
stomach
suppressive T cells
threonine
threonine kinase
toll-like receptors
tsMHC-II
tumor associated antigens
tumor cells
tumor immunotherapy
tumor microenvironment
tumor milieu
tumor necrosis factor
tumor-specific antigens
tumorigenesis
Tyrosine-Based Switch Motif
vaccines
vaccinia virus vaccine
vascular endothelial growth factor
β catenin
β-catenin